(Total Views: 436)
Posted On: 10/24/2019 4:02:54 PM
Post# of 153913
Re: xxxSchlingelxxx #9931
ViiV Healthcare seems to fit your puzzle well. HIV joint venture between GSK (76.5%), PFE (13.5%) and Shionogi (10% who joined in 2012). Checks many of the boxes with HIV, US sales force and Hong Kong Exchange connection.
https://en.m.wikipedia.org/wiki/ViiV_Healthcare
https://en.m.wikipedia.org/wiki/ViiV_Healthcare
(2)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
